Antidepressants, Metabolites, and Apparent Drug Resistance

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Clinical neuropharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00002826-199001001-00005PMID 2116227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bupropion in depression. II. The role of metabolites in clinical outcome.

  1988cited by this paper
• Plasma 10-hydroxynortriptyline and therapeutic response in geriatric depression.

  1988cited by this paper
• Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.

  1988cited by this paper
• Therapeutic indications for serotonin-potentiating compounds: a hypothesis.

  1987cited by this paper
• Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.

  1986cited by this paper
• Psychoses associated with bupropion treatment.

  1985cited by this paper
• Therapeutic responses to tricyclic antidepressants and related drugs in non-affective disorder patient populations.

  1985cited by this paper
• Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro.

  1984cited by this paper
• Case report of tardive dyskinesia and parkinsonism associated with amoxapine therapy.

  1984cited by this paper
• Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors.

  1983cited by this paper
• Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness.

  1983cited by this paper
• Amoxapine — An Antidepressant With Some Neuroleptic Properties?: A Review of Its Chemistry, Animal Pharmacology and Toxicology, Human Pharmacology, and Clinical Efficacy

  1981cited by this paper
• Comparison of peripheral anticholinergic effects of antidepressants: dry mouth

  1981cited by this paper
• E‐ and Z‐10‐hydroxylation of nortriptyline: Relationship to polymorphic debrisoquine hydroxylation

  1981cited by this paper
• Anticholinergic effects and plasma desipramine levels

  1980cited by this paper
• Galactorrhea and hyperprolactinemia associated with amoxapine therapy. Report of a case.

  1979cited by this paper
• Pronounced inhibition of noradrenaline uptake by 10-hydroxymetabolites of nortriptyline.

  1979cited by this paper
• Anticholinergic activity of two tricyclic antidepressants.

  1978cited by this paper
• Metabolism of tricyclic antidepressants. A review.

  1974cited by this paper
• Metabolism of 14C-imipramine: II. Urinary metabolites in man

  1969cited by this paper

• Electricity-driven site-selective deuteration of pharmaceuticals

  2025cites this paper
• Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants

  2021cites this paper
• Pharmacologic therapies for the management of non-neurogenic urinary incontinence in children

  2019cites this paper
• 34 – Psychopharmacology in the Medical Setting

  2011cites this paper
• EFFECT OF INNATE LIPID SOLUBILITY ON BUCCAL ABSORPTION OF BASIC DRUGS

  2007cites this paper
• Initial conditions of psychotropic drug response: studies of serotonin transporter long promoter region (5-HTTLPR), serotonin transporter efficiency, cytokine and kinase gene expression relevant to depression and antidepressant outcome.

  2005cites this paper
• General Principles of Pharmacokinetics

  2004cites this paper
• Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome.

  2002cites this paper
• A Simple High-Performance Liquid Chromatography Method for the Quantitation of Tricyclic Antidepressant Drugs in Human Plasma or Serum

  2000cites this paper
• Metabolism of Tricyclic Antidepressants

  1999cites this paper
• Drug metabolism and psychiatry: introduction.

  1999cites this paper
• Metabolism of Some “Second”– and “Fourth”–Generation Antidepressants: Iprindole, Viloxazine, Bupropion, Mianserin, Maprotiline, Trazodone, Nefazodone, and Venlafaxine

  1999cites this paper
• Drug Metabolism and Psychiatry: Preface

  1999influential citation
• Metabolism of the Newer Antidepressants

  1998cites this paper
• Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology.

  1997cites this paper
• The Role of Metabolites of Antidepressants in the Treatment of Depression

  1997cites this paper
• Application of HPLC with silica-phase and reversed-phase eluents for the determination of clomipramine and demethylated and 8-hydroxylated metabolites.

  1996cites this paper
• Clinical Pharmacokinetics of Fluoxetine

  1994cites this paper
• Derivatization with acetic anhydride: applications to the analysis of biogenic amines and psychiatric drugs by gas chromatography and mass spectrometry.

  1994cites this paper
• Metabolism and chirality in psychopharmacology.

  1994cites this paper
• Clinical Pharmacokinetics of Selective Serotonin Reuptake Inhibitors

  1993cites this paper
• Clinical pharmacokinetics of selective serotonin reuptake inhibitors.

  1993cites this paper
• Pharmacokinetics of antidepressants: why and how they are relevant to treatment.

  1993cites this paper
• Pharmacokinetic and pharmacodynamic significance of antidepressant drug metabolites.

  1992cites this paper
• 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.

  1992cites this paper